Market Overview

Capnia to Present at Upcoming Investor Conferences


REDWOOD CITY, Calif., Sept. 06, 2016 (GLOBE NEWSWIRE) -- Capnia, Inc. (NASDAQ: CAPN), a diversified healthcare company that develops and commercializes innovative diagnostics, devices and therapeutics addressing unmet medical needs, today announced that Anish Bhatnagar, M.D., Chief Executive Officer, will present at two upcoming investor conferences:

  • The Rodman & Renshaw 18th Annual Global Investment Conference on Monday, September 12, 2016 at 12:05 PM ET at the Lotte New York Palace Hotel.
  • The 2016 Aegis Capital Growth Conference on Wednesday, September 21, 2016 at 11:00 AM PT at the Wynn Las Vegas.

The presentations will be webcast live and may be accessed by visiting the "Events & Presentations" section of the Company's website at The webcasts will also be available on the Company's website for a limited period of time following the conferences.

About Capnia

Capnia is a leading provider and developer of innovative healthcare products used for the screening, detection and treatment of medical conditions. Capnia's flagship products, Serenz® Allergy Relief and CoSense® ETCO Monitor, are based on its proprietary technologies, which utilize precision metering of gas flow.  Capnia currently markets Serenz Allergy Relief in the UK and Ireland. The CoSense ETCO Monitor, which measures end-tidal carbon monoxide (ETCO) that can be used to detect hemolysis, and the Infant Solutions product line, including innovative pulmonary resuscitation devices for neonates and infants, are marketed globally.  Capnia is also clinically evaluating its nasal, non-inhaled CO2 technology to treat trigeminally-mediated pain conditions such as cluster headache and trigeminal neuralgia.  For more information, please visit

Investor Relations Contact: Michelle Carroll/Susie Kim Argot Partners (212) 600-1902

Primary Logo

View Comments and Join the Discussion!